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The Universal Declaration of Bioethics and Human Rights (UDBHR) of the United Nations Educational, Scientific and Cultural Organization 
(UNESCO) was adopted unanimously in 2005 by the world community as a universal guideline, according to which members of the global 
community were accountable to each other. Research results from UNESCO show that the UDBHR has had little or no impact in South Africa 
(SA). The primary objective of this article is to promote awareness of the UDBHR in SA and Africa by focusing on Article 9 of the Declaration, 
which accepts the right to privacy and confidentiality. For this objective to be relevant in the SA context, depends on whether the guidelines 
of the National Department of Health’s Ethics in Health Research: Principles, Processes and Structures of 2015 acknowledge biobanks of the 
universally accepted ethical guidelines on privacy and confidentiality of autonomous persons and whether these guidelines are broadly in 
accordance with global bioethical guidelines.
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In this study, Article 9 of the Universal Declaration on Bioethics 
and Human Rights (UDBHR) of the United Nations Educational, 
Scientific and Cultural Organization (UNESCO) is investigated to 
understand and promote the global bioethical norms of privacy 
and confidentiality. Under the heading ‘Privacy and confidentiality’, 
Article 9 reads as follows: ‘The privacy of the persons concerned and 
the confidentiality of their personal information should be respected. 
To the greatest extent possible, such information should not be used 
or disclosed for purposes other than those for which it was collected 
or consented to, consistent with international law, in particular 
international human rights law.’[1] 
The UDBHR is, in my opinion, one of the most important instru-
ments in the development of human rights and bioethics, as the 
international community, comprising 191 member states, accepted 
it unanimously in 2005. This means that the declaration was the first 
global political and bioethical text to which all the governments in 
the world, including South Africa (SA), committed themselves. It 
is the only bioethical document that is so widely accepted.[2-4] The 
primary aim of this article is to promote awareness of the UDBHR in 
SA and Africa. Article 23 of the UDBHR makes an appeal to states 
that have signed the Declaration to promote the principles of Article 9 
by means of education in all areas. Mathooko and Kipkemboi,[5] 
two UDBHR researchers from Africa, are convinced that bioethical 
teaching is necessary on this continent. The research focus arises 
from UNESCO research results, showing that the UDBHR has had 
little or no impact in SA.[6] To bring the primary objective of creating 
awareness of the UDBHR in SA into effect, UNESCO’s understanding 
of respect for the principle of privacy and confidentiality is explained 
briefly. It is also important to consider that the promotion of human 
rights awareness in SA depends on all citizens’ understanding of and 
concurrence with the fundamental content of the UDBHR. With 
regard to the latter, in contrast to all other bioethical instruments, the 
UDBHR is definitely aimed at developing countries.[1] 
Several biobanks that function globally have come into existence, 
also in SA. In June 2010, the National Institutes of Health (USA) 
and Wellcome Trust (UK) lodged a project, Human Heredity and 
Health in Africa (H3Africa), with four biobanks in SA. Biobanks 
are repositories that store human biological materials for research 
purposes specifically. These banks do not only store organised 
collections of human biological materials (usually from a large 
number of donors), but also associated data, including individual 
health records and information derived from their analysis.[1,2] 
Several ethical issues are closely related to the phenomenon of 
biobanks, i.e. informed consent, privacy and confidentiality, sharing 
of benefits, and many other ethical challenges. It is surmised that 
there are >12 biobanks of different sizes in SA,[7-9] but there is 
currently no national instrument that focuses exclusively on the 
ethics of biobanks. The National Health Act No. 61 of 2003 offers 
no ethical guidelines for biobanks;[9] therefore, the only national 
document that is currently directional in this regard is the Ethics 
in Health Research: Principles, Processes and Structures of 2015, 
updated from the 2004 guidelines[7,10] of the Department of Health 
(DoH). In the Foreword and Acknowledgements, this document 
expresses its status as the national policy for conducting research 
responsibly and ethically, as mandated by Section 72 of the National 
Health Act No. 61 of 2003.[10] 
To make the primary goal of the article relevant to the SA context, 
I discuss whether the guidelines of the DoH with regard to biobanks 
incorporate the universally acknowledged ethical guidelines on 
privacy and confidentiality (of autonomous persons) and whether 
these guidelines are broadly in accordance with global bioethical 
guidelines. Commentators of the UDBHR also discuss biobanks in 
the light of Article 9.[11] In the Handbook of Global BioEthics,[5] which 
uses the UDBHR as a frame of reference, it is stated that legislation 
or bioethical instruments in Africa (and by implication in SA) do 
not conform to international bioethical standards.
Consequently, attention is given to Article 9 of the UDBHR; 
thereafter, the ethical guidelines of the DoH are discussed briefly 
to determine whether they are broadly in accordance with global 
bioethical guidelines.
This open-access article is distributed under 
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Global guidelines
In the first instance, the UDBHR relates human dignity and privacy/
confidentiality to each other. According to Article 3 of the UDBHR, 
respect for privacy and confidentiality gives expression to human 
dignity; where these principles are respected, people are treated 
with human dignity.[12-15] From the following statement it is clear 
that UNESCO wanted to formalise these principles: ‘Nevertheless, 
in order to use “dignity” in our lives, some practical principles were 
established.’[13]
In the second instance, privacy or confidentiality is the direct 
outcome of autonomy, which deals (according to Article 5 of the 
UDBHR) with the global recognition that a human being has the 
right to determine the content of his life.[12]
In the third instance, what is UNESCO’s interpretation of the con-
cept of ‘privacy of the persons’? In their explanation of Article 9, both 
Stiennon[14] and Martin,[15] who analyse the UDBHR, use the defini-
tion of the International Bioethics Committee (IBC) of UNESCO as 
found in UNESCO’s Explanatory Memorandum on the Elaboration of 
the Preliminary Draft Declaration on Universal Norms on Bioethics[4] 
of June 2005: ‘A right to privacy guarantees a control over personal 
information in many ways. It restricts access to personal and medical 
information and it provides a claim of non-interference in various 
private spheres of the individual. Privacy extends beyond data pro-
tection, as certain private spheres of the individual that are not mani-
fested in data processing can also be protected by the right to privacy.’
The first fundamental distinguishing norm of the right to privacy is 
the recognition or confirmation that every individual has a personal 
space in which he or she has an autonomous decision-making right. [11,14] 
This personal space includes the whole person (including biologi-
cal, psychological, social, cultural and spiritual dimensions and all 
types of data; see Foreword of the UDBHR[1,13]) and no one has the 
right to enter the personal space (the claim of non-interference) and 
remove and use any material or information of the person.[12] Only 
the person has the right to free his or her space from privacy. This 
private space of persons (who have the capacity to make autonomous 
decisions) is protected or held private by the right of (informed) con-
sent, which can be summarised as follows (Article 6 of the UDBHR): 
‘Any preven tive, diagnostic and therapeutic medical intervention … 
as well as scientific research … is only to be carried out with the 
prior, free and informed consent of the person concerned, based on 
adequate information.’[1,14,15]
The second fundamental distinguishing guideline of the right to 
privacy is the recognition that every individual also has within his 
or her personal space multiple spaces over which he or she has an 
autonomous, decision-making right (see the abovementioned defini-
tion on private spheres). Article 9 of the UDBHR restricts the scope 
of consent or space. This is deduced from the norm that regulates 
privacy, confidentiality and information: ‘The privacy of the persons 
concerned and the confidentiality of their personal information 
should be respected. To the greatest extent possible, such information 
should not be used … for purposes other than those for which it was 
collected or consented to.’[1,14]
From this explanation, it is clear that consent can or must be 
clearly aimed at a specific goal (‘for purposes other than those for 
which it was … consented to’). Consent is very specifically applicable 
to an exact space or spaces within the larger space and does not open 
up the total personal space.[12,14,15] The following two examples serve 
as explanation: (i) consent to use blood samples doesn’t automatically 
open the space to psychological information; and (ii) consent to use 
biological spaces for researching diseases doesn’t mean that biological 
material may be used for creating human embryos.[9] Currently, it 
seems (in line with the draft Declaration on Ethical Considerations 
Regarding Health Databases and Biobanks of the World Medical 
Association (WMA)[16] and in light of the UDBHR’s Article 9) as if 
a concept such as broad informed consent could be problematic, as 
it cannot be specific. Broad consent permits donor use of biological 
materials for future studies, subject only to further prior ethics review 
and approval.[10,13]
In the fourth instance, what is UNESCO’s understanding of the 
concept of confidentiality? In their discussion of this concept, both 
Stiennon[14] and Martin[15] use the definition in the abovementioned 
explanatory memorandum of the IBC: ‘Confidentiality refers to 
a special and often fiduciary relationship, such as that between 
researcher and research subject, or doctor and patient, and provides 
that the shared information shall remain secret, confidential and shall 
not be disclosed to third persons, unless a strictly defined, compelling 
interest justifies disclosure under domestic law.’[4]
The first basic norm with regard to the concept of confidentiality 
is that the person is and remains the lawful and autonomous owner 
of all information that has been attained and moved from the private 
space.[14] This ownership is quite clear from the following UNESCO 
statement: ‘Individuals “own” their information: it is essential to their 
personal integrity.’[12,13] It also means that a person has the right not to 
know and may request not to be informed about a certain situation. 
After death, a person also has the right to privacy and confidentiality.’[15]
The second basic norm is that if a person or persons want to 
share information with others outside the initial consent situation, 
he, she or they have to obtain consent to or exemption from specific 
confidentiality again. Article 9 states clearly that ‘information should 
not be used or disclosed for purposes other than those for which it 
was collected or consented to’.[1] From this, it is clear that consent 
consists of two phases. In a ‘first consent’, information that has a 
specific purpose is entrusted to a very clear, demarcated space. If 
someone wants to move this information from the first space for 
which consent has been given (whatever the reason might be), a 
‘second consent opportunity’ is necessary.[14,15] Currently, it also seems 
(in line with the WMA Draft Declaration on Ethical Considerations 
Regarding Health Databases and Biobanks[16] and in light of the 
UDBHR’s Article 9) as if a concept such as broad informed consent 
could be contentious in this case.
In the fifth instance, UNESCO recognises that the abovementioned 
norm is not absolute in all respects and exceptions are possible. The 
golden rule is that before any confidentiality may be breached, the 
consent of the patient or substitute must be received.[12] Article 9 
regulates that confidentiality should be respected to ‘the greatest 
extent possible’.[1] It means that in exceptional cases, it is permissible 
that the right to confidentiality could be infringed upon. These 
exceptions are described as follows in Article 27 of the UDBHR: ‘If 
the application of the principles of this Declaration is to be limited, 
it should be by law, including laws in the interests of public safety, 
for the investigation, detection and prosecution of criminal offences, 
for the protection of public health or for the protection of the rights 
and freedoms of others. Any such law needs to be consistent with 
international human rights law.’[1,14]
Martin[15] asserts that the interest and wellbeing of the community 
may not easily be used as an argument to justify unlawful infringement 
of the right to privacy and confidentiality. Article 3.2 of the UDBHR 
motivates this truth in the following way: ‘The interests and welfare 
of the individual should have priority over the sole interest of science 
or society.’[1] It means that the respect for privacy and confidentiality 
of the person has greater weight than the interests of science and the 
community. For now, it would appear as if the UDBHR’s possible 
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exception only considers public safety, crime tracing and protection 
of public health (e.g. a highly infectious disease) to infringe upon the 
right to privacy and confidentiality, and does not really leave room 
for the argument of broad consent with a view to research or the 
promotion of the common good of the community. 
In the sixth instance, what is the implication of Article 9 as uni-
versal bioethical principle and human right? Article 9 states clearly 
that the right to privacy and confidentiality must be respected.[1] 
The concept of ‘respect’ has the meaning of ‘protection’ within the 
framework of the Declaration and Article 9.[14] These meanings are 
confirmed by one of the objectives of the UDBHR, i.e. ‘to promote 
respect for human dignity and protect human rights by ensuring 
respect for the life of human beings and fundamental freedoms, 
consistent with international human rights law’ (Article 2, c).[1] This 
protection can be by means of legislation, policy, instruments in 
the field of bioethics (Article 2), ethics committees (Article 19) and 
education in bioethics (Article 23).[1] These guidelines refer to both 
the subject (participant) and the object (researcher) in the context of 
medical care and research.[1,14]
Department of Health guidelines
The DoH’s ethical guidelines with regard to biobanks, privacy and 
confidentiality are discussed briefly. In paragraph 3.5, which deals 
with special topics, the DoH pays attention to the following issues: 
databases, registries and repositories, including biobanks (3.5.2.2). 
As paragraph 3.5 deals very concisely with biobanks (repositories), 
relevant information is collected from the entire document.[10] The 
following conclusions can be drawn:
1.  The DoH states clearly in Chapter 2 (Guiding principles for ethical 
research) that broad ethical principles form the foundation of 
norms: ‘This chapter sets out the broad principles underpinning 
research that inform the norms and standards.’ The specific, 
relevant broad or underlying principle to which the DoH refers 
is ‘respect of persons’ that is described as human dignity and 
autonomy (2.1).
2.  In close relation to this principle, the DoH’s guidelines state in 
Chapter 2 that privacy and confidentiality are two key norms and 
basic rights that flow from the respect for people (human dignity 
and autonomy): ‘The key ethical norms and standards are ongoing 
respect for participants, including privacy and confidentiality’ (2.3; 
2.3.7). SA has a long history of recognising the right to privacy and 
confidentiality in common law[17] and the Constitution.[17] These 
two principles also form part of the HPCSA’s rules and guidelines for 
healthcare professionals in SA.[18]
3.  The DoH’s guidelines[10] provide the following definitions of these 
two key ethical norms:
• Simply stated, privacy is concerned with who has access to 
personal information and records about the participant, including 
clinical health care records (2.3.7; 3.1.8).
• However, ‘confidentiality’ is about ensuring that appropriate 
measures will be implemented to prevent disclosure of information 
that might identify the participant (inadvertently or not), either 
during the course of the research or afterwards (2.3.7; 3.1.8).
4.  It is stated clearly that the privacy and confidentiality of participants 
in research must be protected: 
• Thus researchers and research ethics committees (RECs) should 
pay careful attention to measures that will protect privacy and 
confidentiality interests (2.3.7; 3.1.8; 3.5.2.3).
5.  The different possible ways in which privacy and confidentiality of 
the participants must be protected are indicated briefly: 
• In general terms, a person should know what information is 
being collected, why it is being collected, what will happen to it, 
how long it will be retained, whether it will identify the person, 
whether it will be shared with others and why, whether it will 
be sent outside SA and why. The person should agree to these 
terms.(3.1.8; 3.5.2.3).
• Broad consent: the donor permits use of the specimen for current 
research, for storage and possible future research purposes, even 
though the precise nature of future research may be unclear at 
present. The nature of the further usage should be described as 
fully as possible and should stipulate that further prior ethics 
review of the new study is necessary. Permission may be sought 
to recontact the person if intended future use is outside the 
scope of the current consent (3.3.6).
• The Protection of Personal Information Act No. 4 of 2013 
(partially in effect) has increased the need to ensure computer 
safety, locked record storage facilities and careful gate keeping 
about access to raw data, including completed informed consent 
documents (3.1.8). It should be remembered that research 
records, including informed consent documentation, may be 
solicited by interested parties via application in terms of the 
Promotion of Access to Information Act No. 2 of 2000.
• Researchers should take measures to ensure privacy and confi-
dentiality interests throughout the research period, including 
when disseminating results or findings (2.3.7; 3.1.8).
• Institutions and researchers that maintain repositories (biobanks 
or tissue banks) must have appropriate facilities, equipment, 
policies and procedures to store human biological materials and 
data safely and in compliance with accepted standards (3.5.2.2).
• Appropriate safeguards, including physical, administrative and 
technical, must exist to protect against unauthorised handling 
(3.1.8; 3.5.2.2).
• The location, context and timing of recruitment and enrol-
ment should be appropriate for protection of privacy and 
confidentiality interests (3.1.4).
• The proposal should explain why particular identifying 
information is required for the study that purports to collect 
data anonymously (3.1.8).
• RECs should assess whether notifiable activities might occur 
amongst participants, for example abuse of minors or notifiable 
diseases and, consequently, whether appropriate measures are in 
place and are explained in the research proposal (3.1.8; 3.3.8).
• If the information is to be sent outside the Republic, the 
recipient must assure that the level of protection afforded in that 
country is commensurate with that expected in SA (3.1.8).
• Information about a person’s health or sex life, inherited 
character istics and biometric information must be necessary for 
the research activity (3.1.8).
• Usually, demographic and medical information about the 
donors is included in the repository, as are codes that link the 
material to the donors (3.3.3; 3.5.2.1).
• Anonymised materials without any linkage to donors are 
unlikely to identify a donor (3.3.3).
• Materials collected without identifiers of any kind are unlikely to 
identify an individual donor (3.3.3).
• The consent documentation for donors should explain clearly … 
the conditions and requirements under which data or material 
will be shared with other researchers.(3.5.2.3).
• The consent documentation for donors should explain clearly 
… information about the length of storage time … [and] when 
the current consent to use material or data will expire (3.5.2.3).
• If a translator will be used in the consent process and be present 
for the discussions, the information materials should state that 
privacy will be compromised to that extent (4.5.1.9).
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Conclusion
It is clear that the international community has respect for privacy 
and confidentiality as independent rights and that it regards respect 
for these rights as an obligation of all communities. In summary, 
the conclusion can be drawn that the ethical guidelines of the DoH, 
which also apply to biobanks and research, are broadly in line with the 
universal guidelines as spelled out in the UDBHR. Both documents 
take human dignity and autonomy as a point of departure, from 
which the norms of privacy and confidentiality flow, and they both 
state categorically that privacy and confidentiality must be protected. 
I am of the opinion that there is also a broad but definite agreement 
regarding the understanding of privacy, as both documents state that 
improper access to the person (implied space) is ethically unaccept-
able and that access to privacy is protected by informed consent. With 
regard to confidentiality, the documents state that information will 
be kept secret and may not be disclosed without consent. They also 
state that privacy and confidentiality are possibly not absolute and 
can be ignored in highly exceptional circumstances. It must also be 
mention ed that the SA Constitution recognises the rights of indivi-
duals as being paramount, except where it is ‘reasonable and justifi-
able’ to limit them.[17,18] The UDBHR, though, places greater emphasis 
on the right of the individual than on that of the community, whereas 
the DoH does not mention anything specific on the matter.
In my view, the DoH meets objective 2(d) of the UDBHR as follows: 
‘to recognize the importance of freedom of scientific research  … 
while stressing the need for such research and developments to occur 
within the framework of ethical principles set out in this Declaration 
and to respect human dignity, human rights and fundamental 
freedoms.’[1] It is therefore incorrect to state that national policies 
in SA are not in concurrence with global guidelines regarding the 
regulation of research and biobanks. Nevertheless, the guidelines of 
the DoH must only be understood as a temporary document with 
specific shortcomings. For example, no attention is given to the 
issue of what the ethical implications will be if a biobank has to close 
prematurely or unexpectedly owing to financial problems, which will 
give creditors the right to sell assets and trustees to disregard previous 
contracts, or if no attention is paid to material transfer agreements. [10] 
For the present, it also seems as if the UDBHR does not support the 
idea of broad ‘informed’ consent in Article 9, because privacy and 
confidentiality have to be directed very narrowly (this statement 
needs further study).
In light of this, the appeal by leading SA bioethicists, jurists and 
physicians, such as a A Dhai, S Mahomed and I Sanne, can be sup-
ported, i.e. that an ‘ethico-regulatory framework’ that is exclusively 
focused on biobanks[16] and in concurrence with all the principles 
of the UDBHR and international guidelines for biobanks should be 
developed and implemented in SA in the near future.[7-9]
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